
### [MONDO:0017304](http://purl.obolibrary.org/obo/MONDO_0017304)
**Label:** ocular albinism (disease)

**Subclasses:** [MONDO:0010390](http://purl.obolibrary.org/obo/MONDO_0010390) (ocular albinism with late-onset sensorineural deafness), [MONDO:0018138](http://purl.obolibrary.org/obo/MONDO_0018138) (ocular albinism with congenital sensorineural deafness), [MONDO:0021019](http://purl.obolibrary.org/obo/MONDO_0021019) (X-linked recessive ocular albinism), 

**Mapped go classes:** [GO:0035240](http://purl.obolibrary.org/obo/GO_0035240) (dopamine binding), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:1902908](http://purl.obolibrary.org/obo/GO_1902908) (regulation of melanosome transport), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0032400](http://purl.obolibrary.org/obo/GO_0032400) (melanosome localization), [GO:0072545](http://purl.obolibrary.org/obo/GO_0072545) (tyrosine binding), [GO:0072544](http://purl.obolibrary.org/obo/GO_0072544) (L-DOPA binding), [GO:0070888](http://purl.obolibrary.org/obo/GO_0070888) (E-box binding), [GO:0032402](http://purl.obolibrary.org/obo/GO_0032402) (melanosome transport), [GO:2001141](http://purl.obolibrary.org/obo/GO_2001141) (regulation of RNA biosynthetic process), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:1903056](http://purl.obolibrary.org/obo/GO_1903056) (regulation of melanosome organization), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0032438](http://purl.obolibrary.org/obo/GO_0032438) (melanosome organization), [GO:0004503](http://purl.obolibrary.org/obo/GO_0004503) (monophenol monooxygenase activity), [GO:0042470](http://purl.obolibrary.org/obo/GO_0042470) (melanosome), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0050848](http://purl.obolibrary.org/obo/GO_0050848) (regulation of calcium-mediated signaling), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0033162](http://purl.obolibrary.org/obo/GO_0033162) (melanosome membrane), [GO:0035584](http://purl.obolibrary.org/obo/GO_0035584) (calcium-mediated signaling using intracellular calcium source), [GO:0006461](http://purl.obolibrary.org/obo/GO_0006461) (protein complex assembly), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0006585](http://purl.obolibrary.org/obo/GO_0006585) (dopamine biosynthetic process from tyrosine), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0044336](http://purl.obolibrary.org/obo/GO_0044336) (canonical Wnt signaling pathway involved in negative regulation of apoptotic process), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0045670](http://purl.obolibrary.org/obo/GO_0045670) (regulation of osteoclast differentiation), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0050935](http://purl.obolibrary.org/obo/GO_0050935) (iridophore differentiation), [GO:0046849](http://purl.obolibrary.org/obo/GO_0046849) (bone remodeling), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0004097](http://purl.obolibrary.org/obo/GO_0004097) (catechol oxidase activity), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0030316](http://purl.obolibrary.org/obo/GO_0030316) (osteoclast differentiation), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0030318](http://purl.obolibrary.org/obo/GO_0030318) (melanocyte differentiation), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:2000144](http://purl.obolibrary.org/obo/GO_2000144) (positive regulation of DNA-templated transcription, initiation), [GO:0035643](http://purl.obolibrary.org/obo/GO_0035643) (L-DOPA receptor activity), 

**Class expressions from DL-Learner:**

- [GO:0090741](http://purl.obolibrary.org/obo/GO_0090741) (pigment granule membrane) 52.94%
- [GO:0072545](http://purl.obolibrary.org/obo/GO_0072545) (tyrosine binding) 52.94%
- [GO:0072544](http://purl.obolibrary.org/obo/GO_0072544) (L-DOPA binding) 52.94%
- [GO:0070888](http://purl.obolibrary.org/obo/GO_0070888) (E-box binding) 52.94%
- [GO:0051904](http://purl.obolibrary.org/obo/GO_0051904) (pigment granule transport) 52.94%
- [GO:0051875](http://purl.obolibrary.org/obo/GO_0051875) (pigment granule localization) 52.94%
- [GO:0050935](http://purl.obolibrary.org/obo/GO_0050935) (iridophore differentiation) 52.94%
- [GO:0048770](http://purl.obolibrary.org/obo/GO_0048770) (pigment granule) 52.94%
- [GO:0046849](http://purl.obolibrary.org/obo/GO_0046849) (bone remodeling) 52.94%
- [GO:0044336](http://purl.obolibrary.org/obo/GO_0044336) (canonical Wnt signaling pathway involved in negative regulation of apoptotic process) 52.94%
- [GO:0042470](http://purl.obolibrary.org/obo/GO_0042470) (melanosome) 52.94%
- [GO:0042416](http://purl.obolibrary.org/obo/GO_0042416) (dopamine biosynthetic process) 52.94%
- [GO:0035643](http://purl.obolibrary.org/obo/GO_0035643) (L-DOPA receptor activity) 52.94%
- [GO:0035584](http://purl.obolibrary.org/obo/GO_0035584) (calcium-mediated signaling using intracellular calcium source) 52.94%
- [GO:0035240](http://purl.obolibrary.org/obo/GO_0035240) (dopamine binding) 52.94%


